Orthofix Medical Inc. (NASDAQ:OFIX) Shares Purchased by Sei Investments Co.

Sei Investments Co. raised its position in Orthofix Medical Inc. (NASDAQ:OFIX) by 24.6% during the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 46,195 shares of the medical device company’s stock after purchasing an additional 9,114 shares during the quarter. Sei Investments Co. owned 0.12% of Orthofix Medical worth $613,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also modified their holdings of the company. Vanguard Group Inc. raised its holdings in shares of Orthofix Medical by 0.5% in the 1st quarter. Vanguard Group Inc. now owns 2,008,816 shares of the medical device company’s stock valued at $29,168,000 after buying an additional 9,150 shares during the period. Glenview Capital Management LLC acquired a new stake in shares of Orthofix Medical during the fourth quarter worth about $6,740,000. Boone Capital Management LLC acquired a new stake in shares of Orthofix Medical during the fourth quarter worth about $6,740,000. Great Lakes Advisors LLC boosted its stake in shares of Orthofix Medical by 15.1% in the second quarter. Great Lakes Advisors LLC now owns 259,750 shares of the medical device company’s stock valued at $3,444,000 after purchasing an additional 34,114 shares during the period. Finally, Mutual of America Capital Management LLC grew its holdings in shares of Orthofix Medical by 15.3% in the first quarter. Mutual of America Capital Management LLC now owns 175,671 shares of the medical device company’s stock valued at $2,551,000 after purchasing an additional 23,324 shares in the last quarter. 89.76% of the stock is currently owned by hedge funds and other institutional investors.

Orthofix Medical Price Performance

Orthofix Medical stock opened at $15.10 on Wednesday. The company has a quick ratio of 1.13, a current ratio of 2.48 and a debt-to-equity ratio of 0.24. Orthofix Medical Inc. has a 52-week low of $9.57 and a 52-week high of $17.67. The firm has a market cap of $576.37 million, a PE ratio of -4.47 and a beta of 1.05. The company’s 50 day moving average is $16.25 and its two-hundred day moving average is $14.85.

Orthofix Medical (NASDAQ:OFIX) last posted its quarterly earnings data on Tuesday, August 6th. The medical device company reported ($0.88) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.30) by ($0.58). The company had revenue of $198.62 million for the quarter, compared to analysts’ expectations of $195.75 million. Orthofix Medical had a negative return on equity of 20.68% and a negative net margin of 15.61%. On average, research analysts expect that Orthofix Medical Inc. will post -2.13 EPS for the current fiscal year.

Orthofix Medical Company Profile

Orthofix Medical Inc operates as a spine and orthopedics company in the United States, Italy, Germany, the United Kingdom, France, Brazil, and internationally. It operates through two segments, Global Spine and Global Orthopedics. The Global Spine segment manufactures and distributes bone growth stimulator devices for enhance of bone fusion, including adjunctive and noninvasive treatment of cervical and lumbar spine, as well as a therapeutic treatment for non-spine; designs, develops, and markets a portfolio of motion preservation and fixation implant products, which are used in surgical procedures of the spine; and offers biological products, such as fiber-based and particulate demineralized bone matrices, cellular bone allografts, collagen ceramic matrices, and synthetic bone void fillers, and tissue forms, which allow physicians to treat various spinal and orthopedic conditions.